Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p672 has 217 genes in the original annotation. Currently, there are 167 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
89846	FGD3	ZFYVE5	FYVE, RhoGEF and PH domain containing 3	-
5599	MAPK8	JNK \| JNK-46 \| JNK1 \| JNK1A2 \| JNK21B1/2 \| PRKM8 \| SAPK1 \| SAPK1c	mitogen-activated protein kinase 8	10q11.22
983	CDK1	CDC2 \| CDC28A \| P34CDC2	cyclin-dependent kinase 1	10q21.1
22986	SORCS3	SORCS	sortilin related VPS10 domain containing receptor 3	10q23-q25
5728	PTEN	10q23del \| BZS \| CWS1 \| DEC \| GLM2 \| MHAM \| MMAC1 \| PTEN1 \| TEP1	phosphatase and tensin homolog	10q23.3
1147	CHUK	IKBKA \| IKK-alpha \| IKK1 \| IKKA \| NFKBIKA \| TCF16	conserved helix-loop-helix ubiquitous kinase	10q24-q25
7189	TRAF6	MGC:3310 \| RNF85	TNF receptor associated factor 6	11p12
161	AP2A2	ADTAB \| CLAPA2 \| HIP-9 \| HIP9 \| HYPJ	adaptor related protein complex 2 alpha 2 subunit	11p15.5
3265	HRAS	C-BAS/HAS \| C-H-RAS \| C-HA-RAS1 \| CTLO \| H-RASIDX \| HAMSV \| HRAS1 \| RASH1 \| p21ras	Harvey rat sarcoma viral oncogene homolog	11p15.5
5970	RELA	NFKB3 \| p65	v-rel avian reticuloendotheliosis viral oncogene homolog A	11q13
6199	RPS6KB2	KLS \| P70-beta \| P70-beta-1 \| P70-beta-2 \| S6K-beta2 \| S6K2 \| SRK \| STK14B \| p70(S6K)-beta \| p70S6Kb	ribosomal protein S6 kinase B2	11q13.2
9828	ARHGEF17	P164RHOGEF \| TEM4 \| p164-RhoGEF	Rho guanine nucleotide exchange factor 17	11q13.4
23365	ARHGEF12	LARG \| PRO2792	Rho guanine nucleotide exchange factor 12	11q23.3
3709	ITPR2	ANHD \| CFAP48 \| INSP3R2 \| IP3R2	inositol 1,4,5-trisphosphate receptor type 2	12p11
121512	FGD4	CMT4H \| FRABP \| ZFYVE6	FYVE, RhoGEF and PH domain containing 4	12p11.21
3845	KRAS	C-K-RAS \| CFC2 \| K-RAS2A \| K-RAS2B \| K-RAS4A \| K-RAS4B \| KI-RAS \| KRAS1 \| KRAS2 \| NS \| NS3 \| RALD \| RASK2	Kirsten rat sarcoma viral oncogene homolog	12p12.1
1027	CDKN1B	CDKN4 \| KIP1 \| MEN1B \| MEN4 \| P27KIP1	cyclin-dependent kinase inhibitor 1B	12p13.1-p12
3164	NR4A1	GFRP1 \| HMR \| N10 \| NAK-1 \| NGFIB \| NP10 \| NUR77 \| TR3	nuclear receptor subfamily 4 group A member 1	12q13
466	ATF1	EWS-ATF1 \| FUS/ATF-1 \| TREB36	activating transcription factor 1	12q13
112	ADCY6	AC6 \| LCCS8	adenylate cyclase 6	12q13.12
4193	MDM2	ACTFS \| HDMX \| hdm2	MDM2 proto-oncogene	12q14.3-q15
1848	DUSP6	HH19 \| MKP3 \| PYST1	dual specificity phosphatase 6	12q21.33
11108	PRDM4	PFM1	PR domain 4	12q23.3
2308	FOXO1	FKH1 \| FKHR \| FOXO1A	forkhead box O1	13q14.1
8660	IRS2	IRS-2	insulin receptor substrate 2	13q34
4792	NFKBIA	IKBA \| MAD-3 \| NFKBI	NFKB inhibitor alpha	14q13
6655	SOS2	NS9	SOS Ras/Rho guanine nucleotide exchange factor 2	14q21
5663	PSEN1	AD3 \| FAD \| PS-1 \| PS1 \| S182	presenilin 1	14q24.3
801	CALM1	CALML2 \| CAMI \| CPVT4 \| DD132 \| LQT14 \| PHKD \| caM	calmodulin 1 (phosphorylase kinase, delta)	14q32.11
207	AKT1	AKT \| CWS6 \| PKB \| PKB-ALPHA \| PRKBA \| RAC \| RAC-ALPHA	v-akt murine thymoma viral oncogene homolog 1	14q32.32
5604	MAP2K1	CFC3 \| MAPKK1 \| MEK1 \| MKK1 \| PRKMK1	mitogen-activated protein kinase kinase 1	15q22.1-q22.33
83464	APH1B	APH-1B \| PRO1328 \| PSFL \| TAAV688	aph-1 homolog B, gamma secretase subunit	15q22.2
5607	MAP2K5	HsT17454 \| MAPKK5 \| MEK5 \| PRKMK5	mitogen-activated protein kinase kinase 5	15q23
84894	LINGO1	LERN1 \| LRRN6A \| UNQ201	leucine rich repeat and Ig domain containing 1	15q24.3
11214	AKAP13	AKAP-13 \| AKAP-Lbc \| ARHGEF13 \| BRX \| HA-3 \| Ht31 \| LBC \| PRKA13 \| PROTO-LB \| PROTO-LBC \| c-lbc \| p47	A-kinase anchoring protein 13	15q25.3
4205	MEF2A	ADCAD1 \| RSRFC4 \| RSRFC9 \| mef2	myocyte enhancer factor 2A	15q26
5045	FURIN	FUR \| PACE \| PCSK3 \| SPC1	furin, paired basic amino acid cleaving enzyme	15q26.1
5046	PCSK6	PACE4 \| SPC4	proprotein convertase subtilisin/kexin type 6	15q26.3
5595	MAPK3	ERK-1 \| ERK1 \| ERT2 \| HS44KDAP \| HUMKER1A \| P44ERK1 \| P44MAPK \| PRKM3 \| p44-ERK1 \| p44-MAPK	mitogen-activated protein kinase 3	16p11.2
64223	MLST8	GBL \| GbetaL \| LST8 \| POP3 \| WAT1	MTOR associated protein, LST8 homolog	16p13.3
7249	TSC2	LAM \| PPP1R160 \| TSC4	tuberous sclerosis 2	16p13.3
115	ADCY9	AC9 \| ACIX	adenylate cyclase 9	16p13.3
113	ADCY7	AC7	adenylate cyclase 7	16q12.1
5598	MAPK7	BMK1 \| ERK4 \| ERK5 \| PRKM7	mitogen-activated protein kinase 7	17p11.2
29	ABR	MDB	active BCR-related	17p13.3
1398	CRK	CRKII \| p38	v-crk avian sarcoma virus CT10 oncogene homolog	17p13.3
7531	YWHAE	14-3-3E \| HEL2 \| KCIP-1 \| MDCR \| MDS	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon	17p13.3
4974	OMG	OMGP	oligodendrocyte myelin glycoprotein	17q11.2
26574	AATF	BFR2 \| CHE-1 \| CHE1 \| DED	apoptosis antagonizing transcription factor	17q12
1845	DUSP3	VHR	dual specificity phosphatase 3	17q21
4804	NGFR	CD271 \| Gp80-LNGFR \| TNFRSF16 \| p75(NTR) \| p75NTR	nerve growth factor receptor	17q21-q22
6774	STAT3	ADMIO \| APRF \| HIES	signal transducer and activator of transcription 3 (acute-phase response factor)	17q21.31
2885	GRB2	ASH \| EGFRBP-GRB2 \| Grb3-3 \| MST084 \| MSTP084 \| NCKAP2	growth factor receptor bound protein 2	17q24-q25
5573	PRKAR1A	ACRDYS1 \| ADOHR \| CAR \| CNC \| CNC1 \| PKR1 \| PPNAD1 \| PRKAR1 \| TSE1	protein kinase cAMP-dependent type I regulatory subunit alpha	17q24.2
5578	PRKCA	AAG6 \| PKC-alpha \| PKCA \| PRKACA	protein kinase C alpha	17q24.2
396	ARHGDIA	GDIA1 \| HEL-S-47e \| NPHS8 \| RHOGDI \| RHOGDI-1	Rho GDP dissociation inhibitor (GDI) alpha	17q25.3
116	ADCYAP1	PACAP	adenylate cyclase activating polypeptide 1 (pituitary)	18p11
6014	RIT2	RIBA \| RIN \| ROC2	Ras-like without CAAX 2	18q12.3
5605	MAP2K2	CFC4 \| MAPKK2 \| MEK2 \| MKK2 \| PRKMK2	mitogen-activated protein kinase kinase 2	19p13.3
4099	MAG	GMA \| S-MAG \| SIGLEC-4A \| SIGLEC4A \| SPG75	myelin associated glycoprotein	19q13.1
208	AKT2	HIHGHH \| PKBB \| PKBBETA \| PRKBB \| RAC-BETA	v-akt murine thymoma viral oncogene homolog 2	19q13.1-q13.2
55851	PSENEN	MDS033 \| MSTP064 \| PEN-2 \| PEN2	presenilin enhancer gamma secretase subunit	19q13.12
2931	GSK3A	-	glycogen synthase kinase 3 alpha	19q13.2
64857	PLEKHG2	ARHGEF42 \| CLG \| LDAMD	pleckstrin homology and RhoGEF domain containing G2	19q13.2
808	CALM3	HEL-S-72 \| PHKD \| PHKD3	calmodulin 3 (phosphorylase kinase, delta)	19q13.2-q13.3
5296	PIK3R2	MPPH \| MPPH1 \| P85B \| p85 \| p85-BETA	phosphoinositide-3-kinase regulatory subunit 2	19q13.2-q13.4
5518	PPP2R1A	MRD36 \| PP2A-Aalpha \| PP2AAALPHA \| PR65A	protein phosphatase 2 regulatory subunit A, alpha	19q13.41
6195	RPS6KA1	HU-1 \| MAPKAPK1A \| RSK \| RSK1 \| p90Rsk	ribosomal protein S6 kinase A1	1p
4803	NGF	Beta-NGF \| HSAN5 \| NGFB	nerve growth factor	1p13.1
4893	NRAS	ALPS4 \| CMNS \| N-ras \| NCMS \| NRAS1 \| NS6	neuroblastoma RAS viral (v-ras) oncogene homolog	1p13.2
10451	VAV3	-	vav guanine nucleotide exchange factor 3	1p13.3
5906	RAP1A	C21KG \| G-22K \| KREV-1 \| KREV1 \| RAP1 \| SMGP21	RAP1A, member of RAS oncogene family	1p13.3
5567	PRKACB	PKA C-beta \| PKACB	protein kinase cAMP-activated catalytic subunit beta	1p31.1
3065	HDAC1	GON-10 \| HD1 \| RPD3 \| RPD3L1	histone deacetylase 1	1p34
51107	APH1A	6530402N02Rik \| APH-1 \| APH-1A \| CGI-78	aph-1 homolog A, gamma secretase subunit	1p36.13-q31.3
2475	MTOR	FRAP \| FRAP1 \| FRAP2 \| RAFT1 \| RAPT1 \| SKS	mechanistic target of rapamycin	1p36.2
842	CASP9	APAF-3 \| APAF3 \| ICE-LAP6 \| MCH6 \| PPP1R56	caspase 9	1p36.21
9826	ARHGEF11	GTRAP48 \| PDZ-RHOGEF	Rho guanine nucleotide exchange factor 11	1q21
9181	ARHGEF2	GEF \| GEF-H1 \| GEFH1 \| LFP40 \| P40	Rho/Rac guanine nucleotide exchange factor 2	1q21-q22
4914	NTRK1	MTC \| TRK \| TRK1 \| TRKA \| Trk-A \| p140-TrkA	neurotrophic tyrosine kinase, receptor, type 1	1q21-q22
9261	MAPKAPK2	MAPKAP-K2 \| MK-2 \| MK2	mitogen-activated protein kinase-activated protein kinase 2	1q32
84033	OBSCN	ARHGEF30 \| UNC89	obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF	1q42.13
5664	PSEN2	AD3L \| AD4 \| CMD1V \| PS2 \| STM2	presenilin 2	1q42.13
10000	AKT3	MPPH \| MPPH2 \| PKB-GAMMA \| PKBG \| PRKBG \| RAC-PK-gamma \| RAC-gamma \| STK-2	v-akt murine thymoma viral oncogene homolog 3	1q44
57761	TRIB3	C20orf97 \| NIPK \| SINK \| SKIP3 \| TRB3	tribbles pseudokinase 3	20p13-p12.2
6714	SRC	ASV \| SRC1 \| c-SRC \| p60-Src	SRC proto-oncogene, non-receptor tyrosine kinase	20q12-q13
5335	PLCG1	NCKAP3 \| PLC-II \| PLC1 \| PLC148 \| PLCgamma1	phospholipase C gamma 1	20q12-q13.1
7529	YWHAB	GW128 \| HEL-S-1 \| HS1 \| KCIP-1 \| YWHAA	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta	20q13.1
57580	PREX1	P-REX1	phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1	20q13.13
6453	ITSN1	ITSN \| SH3D1A \| SH3P17	intersectin 1	21q22.1-q22.2
7074	TIAM1	-	T-cell lymphoma invasion and metastasis 1	21q22.11
5594	MAPK1	ERK \| ERK-2 \| ERK2 \| ERT1 \| MAPK2 \| P42MAPK \| PRKM1 \| PRKM2 \| p38 \| p40 \| p41 \| p41mapk \| p42-MAPK	mitogen-activated protein kinase 1	22q11.21
135	ADORA2A	A2aR \| ADORA2 \| RDC8	adenosine A2a receptor	22q11.23
10126	DNAL4	MRMV3 \| PIG27	dynein axonemal light chain 4	22q13.1
5600	MAPK11	P38B \| P38BETA2 \| PRKM11 \| SAPK2 \| SAPK2B \| p38-2 \| p38Beta	mitogen-activated protein kinase 11	22q13.33
6300	MAPK12	ERK-6 \| ERK3 \| ERK6 \| MAPK 12 \| P38GAMMA \| PRKM12 \| SAPK-3 \| SAPK3	mitogen-activated protein kinase 12	22q13.33
57142	RTN4	ASY \| NI220/250 \| NOGO \| NOGO-A \| NOGOC \| NSP \| NSP-CL \| Nbla00271 \| Nbla10545 \| Nogo-B \| Nogo-C \| RTN-X \| RTN4-A \| RTN4-B1 \| RTN4-B2 \| RTN4-C	reticulon 4	2p16.3
5581	PRKCE	PKCE \| nPKC-epsilon	protein kinase C epsilon	2p21
805	CALM2	CAMII \| LQT15 \| PHKD \| PHKD2 \| caM	calmodulin 2 (phosphorylase kinase, delta)	2p21
109	ADCY3	AC-III \| AC3	adenylate cyclase 3	2p23.3
57498	KIDINS220	ARMS	kinase D-interacting substrate 220kDa	2p24
6868	ADAM17	ADAM18 \| CD156B \| CSVP \| NISBD \| NISBD1 \| TACE	ADAM metallopeptidase domain 17	2p25
10018	BCL2L11	BAM \| BIM \| BOD	BCL2 like 11	2q13
5899	RALB	-	v-ral simian leukemia viral oncogene homolog B	2q14.2
50649	ARHGEF4	ASEF \| ASEF1 \| GEF4 \| STM6	Rho guanine nucleotide exchange factor 4	2q22
5136	PDE1A	CAM-PDE-1A \| HCAM-1 \| HCAM1 \| HSPDE1A	phosphodiesterase 1A	2q32.1
1385	CREB1	CREB \| CREB-1	cAMP responsive element binding protein 1	2q34
3667	IRS1	HIRS-1	insulin receptor substrate 1	2q36
25791	NGEF	ARHGEF27 \| EPHEXIN	neuronal guanine nucleotide exchange factor	2q37
50650	ARHGEF3	GEF3 \| STA3 \| XPLN	Rho guanine nucleotide exchange factor 3	3p14.3
1849	DUSP7	MKPX \| PYST2	dual specificity phosphatase 7	3p21
387	RHOA	ARH12 \| ARHA \| RHO12 \| RHOH12	ras homolog family member A	3p21.3
7867	MAPKAPK3	3PK \| MAPKAP-K3 \| MAPKAP3 \| MAPKAPK-3 \| MK-3	mitogen-activated protein kinase-activated protein kinase 3	3p21.3
5576	PRKAR2A	PKR2 \| PRKAR2	protein kinase cAMP-dependent type II regulatory subunit alpha	3p21.3-p21.2
5580	PRKCD	ALPS3 \| CVID9 \| MAY1 \| PKCD \| nPKC-delta	protein kinase C delta	3p21.31
4615	MYD88	MYD88D	myeloid differentiation primary response 88	3p22
5894	RAF1	CMD1NN \| CRAF \| NS5 \| Raf-1 \| c-Raf	Raf-1 proto-oncogene, serine/threonine kinase	3p25
8997	KALRN	ARHGEF24 \| CHD5 \| CHDS5 \| DUET \| DUO \| HAPIP \| TRAD	kalirin, RhoGEF kinase	3q21.2
5291	PIK3CB	P110BETA \| PI3K \| PI3KBETA \| PIK3C1	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta	3q22.3
1894	ECT2	ARHGEF31	epithelial cell transforming 2	3q26.1-q26.2
5290	PIK3CA	CLOVE \| CWS5 \| MCAP \| MCM \| MCMTC \| PI3K \| p110-alpha	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	3q26.3
1173	AP2M1	AP50 \| CLAPM1 \| mu2	adaptor related protein complex 2 mu 1 subunit	3q28
836	CASP3	CPP32 \| CPP32B \| SCA-1	caspase 3	4q34
253260	RICTOR	AVO3 \| PIA \| hAVO3	RPTOR independent companion of MTOR, complex 2	5p13.1
7204	TRIO	ARHGEF23 \| tgat	trio Rho guanine nucleotide exchange factor	5p15.2
108	ADCY2	AC2 \| HBAC2	adenylate cyclase 2 (brain)	5p15.3
5924	RASGRF2	GRF2 \| RAS-GRF2	Ras protein specific guanine nucleotide releasing factor 2	5q13
5295	PIK3R1	AGM7 \| GRB1 \| IMD36 \| p85 \| p85-ALPHA	phosphoinositide-3-kinase regulatory subunit 1	5q13.1
4208	MEF2C	C5DELq14.3 \| DEL5q14.3	myocyte enhancer factor 2C	5q14.3
814	CAMK4	CaMK IV \| CaMK-GR \| IV \| caMK	calcium/calmodulin-dependent protein kinase IV	5q21.3
8841	HDAC3	HD3 \| RPD3 \| RPD3-2	histone deacetylase 3	5q31
5515	PPP2CA	PP2Ac \| PP2CA \| PP2Calpha \| RP-C	protein phosphatase 2 catalytic subunit alpha	5q31.1
8878	SQSTM1	A170 \| FTDALS3 \| OSIL \| PDB3 \| ZIP3 \| p60 \| p62 \| p62B	sequestosome 1	5q35
3710	ITPR3	IP3R \| IP3R3	inositol 1,4,5-trisphosphate receptor type 3	6p21
221472	FGD2	ZFYVE4	FYVE, RhoGEF and PH domain containing 2	6p21.2
1026	CDKN1A	CAP20 \| CDKN1 \| CIP1 \| MDA-6 \| P21 \| SDI1 \| WAF1 \| p21CIP1	cyclin-dependent kinase inhibitor 1A	6p21.2
1432	MAPK14	CSBP \| CSBP1 \| CSBP2 \| CSPB1 \| EXIP \| Mxi2 \| PRKM14 \| PRKM15 \| RK \| SAPK2A \| p38 \| p38ALPHA	mitogen-activated protein kinase 14	6p21.3-p21.2
2309	FOXO3	AF6q21 \| FKHRL1 \| FKHRL1P2 \| FOXO2 \| FOXO3A	forkhead box O3	6q21
3066	HDAC2	HD2 \| RPD3 \| YAF1	histone deacetylase 2	6q21
26230	TIAM2	STEF \| TIAM-2	T-cell lymphoma invasion and metastasis 2	6q25.2
6196	RPS6KA2	HU-2 \| MAPKAPK1C \| RSK \| RSK3 \| S6K-alpha \| S6K-alpha2 \| p90-RSK3 \| p90RSK2 \| pp90RSK3	ribosomal protein S6 kinase A2	6q27
107	ADCY1	AC1 \| DFNB44	adenylate cyclase 1 (brain)	7p12.3
117	ADCYAP1R1	PAC1 \| PAC1R \| PACAPR \| PACAPRI	ADCYAP receptor type I	7p14
5898	RALA	RAL	v-ral simian leukemia viral oncogene homolog A (ras related)	7p15-p13
5879	RAC1	MIG5 \| Rac-1 \| TC-25 \| p21-Rac1	ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)	7p22
5575	PRKAR1B	PRKAR1	protein kinase cAMP-dependent type I regulatory subunit beta	7p22
5577	PRKAR2B	PRKAR2 \| RII-BETA	protein kinase cAMP-dependent type II regulatory subunit beta	7q22
673	BRAF	B-RAF1 \| BRAF1 \| NS7 \| RAFB1	B-Raf proto-oncogene, serine/threonine kinase	7q34
835	CASP2	CASP-2 \| ICH1 \| NEDD-2 \| NEDD2 \| PPP1R57	caspase 2	7q34-q35
3551	IKBKB	IKK-beta \| IKK2 \| IKKB \| IMD15 \| NFKBIKB	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta	8p11.2
1846	DUSP4	HVH2 \| MKP-2 \| MKP2 \| TYP	dual specificity phosphatase 4	8p12-p11
8767	RIPK2	CARD3 \| CARDIAK \| CCK \| GIG30 \| RICK \| RIP2	receptor interacting serine/threonine kinase 2	8q21
114	ADCY8	AC8 \| ADCY3 \| HBAC1	adenylate cyclase 8 (brain)	8q24
1211	CLTA	LCA	clathrin light chain A	9p13
5568	PRKACG	BDPLT19 \| KAPG \| PKACg	protein kinase cAMP-activated catalytic subunit gamma	9q13
5125	PCSK5	PC5 \| PC6 \| PC6A \| SPC6	proprotein convertase subtilisin/kexin type 5	9q21.3
4915	NTRK2	GP145-TrkB \| TRKB \| trk-B	neurotrophic tyrosine kinase, receptor, type 2	9q22.1
53358	SHC3	N-Shc \| NSHC \| RAI \| SHCC	SHC (Src homology 2 domain containing) transforming protein 3	9q22.1
1759	DNM1	DNM \| EIEE31	dynamin 1	9q34
2889	RAPGEF1	C3G \| GRF2	Rap guanine nucleotide exchange factor 1	9q34.3
5900	RALGDS	RGDS \| RGF \| RalGEF	ral guanine nucleotide dissociation stimulator	9q34.3
2002	ELK1	-	ELK1, ETS transcription factor	Xp11.2
6197	RPS6KA3	CLS \| HU-3 \| ISPK-1 \| MAPKAPK1B \| MRX19 \| RSK \| RSK2 \| S6K-alpha3 \| p90-RSK2 \| pp90RSK2	ribosomal protein S6 kinase A3	Xp22.2-p22.1
23229	ARHGEF9	COLLYBISTIN \| EIEE8 \| HPEM-2 \| PEM-2 \| PEM2	Cdc42 guanine nucleotide exchange factor 9	Xq11.1
4168	MCF2	ARHGEF21 \| DBL	MCF.2 cell line derived transforming sequence	Xq27
393	ARHGAP4	C1 \| RGC1 \| RhoGAP4 \| SrGAP4 \| p115	Rho GTPase activating protein 4	Xq28
3654	IRAK1	IRAK \| pelle	interleukin 1 receptor associated kinase 1	Xq28